Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter F. Brennan currently holds 13,850,181 shares of CALMARE THERAPEUTICS Inc (CTTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter F. Brennan has been a net neutral trader of CTTC stock. They have purchased $0 and sold $0 worth of shares.
Peter F. Brennan's most recent insider trade was on Feb 12, 2018, when they sold 4,594,117 shares at $0.00 per share.
Peter F. Brennan serves as Executive at CALMARE THERAPEUTICS Inc (CTTC). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Peter F. Brennan holds the position of Executive at CALMARE THERAPEUTICS Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Peter F. Brennan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter F. Brennan was on Dec 28, 2012, when they sold $57.3K worth of CTTC shares. This transaction involved 121,960 shares at $0.47 per share.
Peter F. Brennan currently owns 13,850,181 shares of CALMARE THERAPEUTICS Inc (CTTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter F. Brennan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter F. Brennan has 6 Form 4 filings on record as an insider at CALMARE THERAPEUTICS Inc.
Set alerts for Peter F. Brennan and 40,000+ other insiders.